第一作者:
Dan J,Woodcock
第一单位:
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
作者:
Dan J,Woodcock [1]
;
Atef,Sahli [2]
;
Ruxandra,Teslo [3]
;
Vinayak,Bhandari [4]
;
Andreas J,Gruber [5]
;
Aleksandra,Ziubroniewicz [6]
;
Gunes,Gundem [7]
;
Yaobo,Xu [8]
;
Adam,Butler [8]
;
Ezequiel,Anokian [9]
;
Bernard J,Pope [10]
;
Chol-Hee,Jung [11]
;
Maxime,Tarabichi [12]
;
Stefan C,Dentro [13]
;
J Henry R,Farmery [14]
;
CRUK ICGC Prostate Group [15]
;
Peter,Van Loo [16]
;
Anne Y,Warren [17]
;
Vincent,Gnanapragasam [18]
;
Freddie C,Hamdy [19]
;
G Steven,Bova [20]
;
Christopher S,Foster [21]
;
David E,Neal [22]
;
Yong-Jie,Lu [9]
;
Zsofia,Kote-Jarai [4]
;
Michael,Fraser [23]
;
Robert G,Bristow [24]
;
Paul C,Boutros [25]
;
Anthony J,Costello [25]
;
Niall M,Corcoran [25]
;
Christopher M,Hovens [26]
;
Charlie E,Massie [27]
;
Andy G,Lynch [28]
;
Daniel S,Brewer [29]
;
Rosalind A,Eeles [30]
;
Colin S,Cooper [31]
;
David C,Wedge
作者单位:
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
[1]
Nuffield Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
[2]
Big Data Institute, University of Oxford, Oxford, UK.
[3]
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
[4]
Nuffield Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK; Department of Biology, University of Konstanz, Konstanz, Germany.
[5]
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
[6]
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
[7]
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
[8]
The Institute of Cancer Research, London, UK.
[9]
Melbourne Bioinformatics, University of Melbourne, Melbourne, VIC, Australia; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia; Department of Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia.
[10]
Melbourne Bioinformatics, University of Melbourne, Melbourne, VIC, Australia.
[11]
The Francis Crick Institute, London, UK; Institute of Interdisciplinary Research (IRIBHM), Universite Libre de Bruxelles, Brussels, Belgium.
[12]
Nuffield Department of Medicine, University of Oxford, Oxford, UK; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK; The Francis Crick Institute, London, UK.
[13]
Statistics and Computational Biology Laboratory, Cancer Research UK Cambridge Institute, Cambridge, UK.
[14]
The Francis Crick Institute, London, UK; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[15]
Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
[16]
Cambridge Urology Translational Research and Clinical Trials Office, Addenbrooke's Hospital, Cambridge, UK; Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
[17]
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
[18]
Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.
[19]
HCA Laboratories, London, UK.
[20]
Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, UK; Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
[21]
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
[22]
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Division of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; CRUK Manchester Institute, University of Manchester, Manchester, UK; Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
[23]
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Departments of Human Genetics and Urology, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
[24]
Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia; Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia.
[25]
Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, UK; Early Detection Programme and Urological Malignancies Programme, Cancer Research UK Cambridge Centre, Department of Oncology, University of Cambridge, Cambridge, UK.
[26]
Statistics and Computational Biology Laboratory, Cancer Research UK Cambridge Institute, Cambridge, UK; School of Medicine/School of Mathematics and Statistics, University of St Andrews, St Andrews, UK.
[27]
Norwich Medical School, University of East Anglia, Norwich, UK; Earlham Institute, Norwich, UK. Electronic address: d.brewer@uea.ac.uk.
[28]
The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: ros.eeles@icr.ac.uk.
[29]
The Institute of Cancer Research, London, UK; Norwich Medical School, University of East Anglia, Norwich, UK. Electronic address: colin.cooper@uea.ac.uk.
[30]
Nuffield Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK; Manchester Cancer Research Centre, University of Manchester, Manchester, UK; Oxford NIHR Biomedical Research Centre, Oxford, UK; Manchester NIHR Biomedical Research Centre, Manchester, UK. Electronic address: david.wedge@manchester.ac.uk.
[31]
医学主题词
男(雄)性(Male);人类(Humans);前列腺肿瘤(Prostatic Neoplasms);前列腺(Prostate);突变(Mutation);基因组学(Genomics);进化, 分子(Evolution, Molecular)
DOI
10.1016/j.xgen.2024.100511
PMID
38428419
发布时间
2024-05-10
- 浏览1
Cell genomics
Cell genomics
2024年4卷3期
100511页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



